Delivery Order SPE2DB22D3004-SPE2DB25FRC01
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. This competitively awarded, non-set-aside contract is classified as firm fixed price and was executed on August 22, 2025, with an ultimate completion date of August 25, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation of diazepam used for acute seizure management,...
- The Defense Logistics Agency awarded a delivery order valued at $1,165.34 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on September 22, 2025, with completion expected by September 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is an FDA-approved nasal spray formulation of diazepam used for acute seizure cluster treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $6,761.00 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, with an ultimate completion date of August 1, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a FDA-approved nasal spray formulation of diazepam used for acute seizure management, making this procurement part of the...
- The Defense Logistics Agency awarded a delivery order valued at $11,266.50 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with a firm fixed price and an ultimate completion date of August 29, 2025. This non-set-aside contract was competitively awarded on August 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation of diazepam used for acute seizure management, representing a specialized...
- The Defense Logistics Agency awarded a delivery order contract valued at $1,380.60 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation of diazepam used for acute seizure management, representing specialized pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,126.10 for Valtoco 5 mg nasal sprays, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $4,533.32 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with an ultimate completion date of September 17, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation of diazepam used for acute seizure management, representing a specialized pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,136.67 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Valtoco is an FDA-approved nasal spray formulation of diazepam used for acute repetitive seizure clusters, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $3,580.78 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is an FDA-approved nasal spray formulation of diazepam used for acute seizure management, representing a specialty...
- The Defense Logistics Agency awarded a delivery order valued at $1,563.78 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of September 10, 2025. This firm fixed-price contract represents a non-competitive award executed on September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a FDA-approved nasal spray formulation of diazepam used for acute seizure management in patients with epilepsy. This delivery...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRC01Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,317.38 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on June 16, 2025, with completion scheduled for June 17, 2025. This firm fixed-price contract represents a non-set-aside competitive award, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation of diazepam used for acute seizure management, indicating this delivery supports federal military healthcare needs through the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a potential value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply a wide range of medications and medical commodities to military healthcare systems and other government healthcare entities. The company's federal procurement portfolio demonstrates consistent success in competitively awarded contracts across multiple therapeutic domains, positioning it as a key supplier for the Defense Health Agency and related federal medical programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/16/25 |